FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Chemplast Sanmar IPO and Windlas Biotech IPO.
Chemplast Sanmar IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Chemplast Sanmar IPO | Windlas Biotech IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Ambit Private Limited Axis Capital Limited Bob Capital Markets Limited Credit Suisse Securities (India) Private Limited Hdfc Bank Limited ICICI Securities Limited Iifl Securities Ltd Indusind Bank Limited Yes Securities (India) Limited |
Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Iifl Securities Ltd SBI Capital Markets Limited |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Chemplast Sanmar IPO is up to ₹3,850.00 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Chemplast Sanmar IPO is ₹541.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
Chemplast Sanmar IPO | Windlas Biotech IPO | |
---|---|---|
Face Value | ₹5 per share | ₹5 per share |
Issue Price (Lower) | ₹530.00 per share | ₹448.00 per share |
Issue Price (Upper) | ₹541.00 per share | ₹460.00 per share |
Issue Price (Final) | ₹541.00 per share | ₹460.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 27 shares | 30 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹1,300.00 Cr | up to ₹165.00 Cr |
OFS Issue Size | 51,42,067 shares | |
OFS Issue Size (Amount) | up to ₹2,550.00 Cr | up to ₹236.54 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹3,850.00 Cr | up to ₹401.54 Cr |
Chemplast Sanmar IPO opens on Aug 10, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Chemplast Sanmar IPO and Windlas Biotech IPO is Aug 12, 2021, and Aug 06, 2021, respectively.
Chemplast Sanmar IPO | Windlas Biotech IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Aug 10, 2021 | Aug 04, 2021 |
Issue Close | Aug 12, 2021 | Aug 06, 2021 |
Basis Of Allotment (Tentative) | Aug 18, 2021 | Aug 11, 2021 |
Initiation of Refunds (Tentative) | Aug 20, 2021 | Aug 12, 2021 |
Credit of Share (Tentative) | Aug 23, 2021 | Aug 13, 2021 |
Listing date (Tentative) | Aug 24, 2021 | Aug 16, 2021 |
Anchor Lockin End date 1 | Sep 17, 2021 | Sep 10, 2021 |
Anchor Lockin End date 2 | Nov 16, 2021 | Nov 09, 2021 |
Chemplast Sanmar IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
Chemplast Sanmar IPO | Windlas Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 78% | ||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 54.99% | 65.16% | ||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Chemplast Sanmar IPO retail investors (RII) are offered 72,64,150 shares while in Windlas Biotech IPO retail investors are offered 72,64,150 shares. Qualified institutional buyers (QIB) are offered 2,17,92,453 shares in Chemplast Sanmar IPO and 17,23,700 shares in Windlas Biotech IPO.
Chemplast Sanmar IPO | Windlas Biotech IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 2,17,92,453 shares | 17,23,700 shares |
NII | 1,08,96,226 shares | 13,23,766 shares |
RII | 72,64,150 shares | 30,88,786 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 3,99,52,829 shares | 61,36,252 shares |
Chemplast Sanmar IPO subscribed 2.17x in total, whereas Windlas Biotech IPO subscribed 22.44x.
Chemplast Sanmar IPO | Windlas Biotech IPO | |
---|---|---|
QIB (times) | 2.70x | 24.40x |
NII (times) | 1.03x | 15.73x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 2.29x | 24.22x |
Employee (times) | ||
Other (times) | ||
Total (times) | 2.17x | 22.44x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|